These movements complement your overall GLP-1 management strategy and can be performed daily without any risk of overdoing it
The study is a retrospective review of the electronic medical records (EMRs) of patients in the Mayo Clinic Health System using semaglutide for the treatment of people diagnosed overweight or obese (BMI greater than 27 kg/m2) between January 1, 2021, and March 31, 2023
What makes our approach different: Same-week appointments available Start your GLP-1 treatment without long wait times Direct access to your clinician Get ongoing guidance, adjustments, and answers when you need them No insurance delays or restrictions Transparent, straightforward care so you can start treatment faster Personalized dosing and treatment plans Your program is tailored to your body, goals, and responsenot a fixed protocol Youre getting real medical care focused on results and safety Realistic Weight Loss Results with GLP-1 Medications GLP-1 medications like Semaglutide and Tirzepatide are among the most effective tools we have for sustainable weight loss
The basic science is intriguing, Frank says
BZ: Project administration, Resources, Writing review & editing
Results have not been independently verified and may vary from person to person
